nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—seminal vesicle—testicular cancer	0.0314	0.162	CbGeAlD
Nelarabine—POLA1—seminal vesicle—testicular cancer	0.0194	0.1	CbGeAlD
Nelarabine—DGUOK—female gonad—testicular cancer	0.0184	0.0954	CbGeAlD
Nelarabine—DGUOK—testis—testicular cancer	0.0163	0.0846	CbGeAlD
Nelarabine—DCK—embryo—testicular cancer	0.0127	0.0658	CbGeAlD
Nelarabine—DCK—seminal vesicle—testicular cancer	0.0119	0.0618	CbGeAlD
Nelarabine—DGUOK—lymph node—testicular cancer	0.0118	0.0613	CbGeAlD
Nelarabine—POLA1—female gonad—testicular cancer	0.0114	0.0588	CbGeAlD
Nelarabine—POLA1—testis—testicular cancer	0.0101	0.0522	CbGeAlD
Nelarabine—ADA—testis—testicular cancer	0.00935	0.0484	CbGeAlD
Nelarabine—DCK—gonad—testicular cancer	0.00863	0.0446	CbGeAlD
Nelarabine—POLA1—lymph node—testicular cancer	0.00731	0.0378	CbGeAlD
Nelarabine—DCK—female gonad—testicular cancer	0.00701	0.0363	CbGeAlD
Nelarabine—ADA—lymph node—testicular cancer	0.00678	0.0351	CbGeAlD
Nelarabine—DCK—testis—testicular cancer	0.00622	0.0322	CbGeAlD
Nelarabine—DCK—Doxorubicin—Epirubicin—testicular cancer	0.00587	0.519	CbGdCrCtD
Nelarabine—DCK—Epirubicin—Doxorubicin—testicular cancer	0.00543	0.481	CbGdCrCtD
Nelarabine—DCK—lymph node—testicular cancer	0.00451	0.0233	CbGeAlD
Nelarabine—Hypoglycaemia—Doxorubicin—testicular cancer	0.000745	0.000937	CcSEcCtD
Nelarabine—Loss of consciousness—Etoposide—testicular cancer	0.000742	0.000933	CcSEcCtD
Nelarabine—Lethargy—Doxorubicin—testicular cancer	0.000742	0.000933	CcSEcCtD
Nelarabine—Ataxia—Epirubicin—testicular cancer	0.000739	0.000929	CcSEcCtD
Nelarabine—Nervous system disorder—Cisplatin—testicular cancer	0.000738	0.000928	CcSEcCtD
Nelarabine—Cough—Etoposide—testicular cancer	0.000737	0.000927	CcSEcCtD
Nelarabine—Thrombocytopenia—Cisplatin—testicular cancer	0.000737	0.000926	CcSEcCtD
Nelarabine—Blood creatinine increased—Epirubicin—testicular cancer	0.000736	0.000926	CcSEcCtD
Nelarabine—Asthenia—Bleomycin—testicular cancer	0.000733	0.000921	CcSEcCtD
Nelarabine—Convulsion—Etoposide—testicular cancer	0.000732	0.00092	CcSEcCtD
Nelarabine—Dehydration—Epirubicin—testicular cancer	0.000731	0.000919	CcSEcCtD
Nelarabine—Pain in extremity—Doxorubicin—testicular cancer	0.000727	0.000914	CcSEcCtD
Nelarabine—Osteoarthritis—Doxorubicin—testicular cancer	0.000727	0.000914	CcSEcCtD
Nelarabine—Feeling abnormal—Ifosfamide—testicular cancer	0.000719	0.000904	CcSEcCtD
Nelarabine—Chest pain—Etoposide—testicular cancer	0.000719	0.000904	CcSEcCtD
Nelarabine—Nausea—Vinblastine—testicular cancer	0.000718	0.000903	CcSEcCtD
Nelarabine—Anorexia—Cisplatin—testicular cancer	0.000717	0.000902	CcSEcCtD
Nelarabine—Hypokalaemia—Epirubicin—testicular cancer	0.000715	0.000899	CcSEcCtD
Nelarabine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000714	0.000897	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000708	0.00089	CcSEcCtD
Nelarabine—Hypotension—Cisplatin—testicular cancer	0.000703	0.000884	CcSEcCtD
Nelarabine—Confusional state—Etoposide—testicular cancer	0.000695	0.000874	CcSEcCtD
Nelarabine—Muscular weakness—Epirubicin—testicular cancer	0.000693	0.000872	CcSEcCtD
Nelarabine—Abdominal pain—Ifosfamide—testicular cancer	0.00069	0.000867	CcSEcCtD
Nelarabine—Body temperature increased—Ifosfamide—testicular cancer	0.00069	0.000867	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000685	0.000862	CcSEcCtD
Nelarabine—Infection—Etoposide—testicular cancer	0.000685	0.000861	CcSEcCtD
Nelarabine—Abdominal distension—Epirubicin—testicular cancer	0.000684	0.00086	CcSEcCtD
Nelarabine—Ataxia—Doxorubicin—testicular cancer	0.000684	0.00086	CcSEcCtD
Nelarabine—Asthenia—Dactinomycin—testicular cancer	0.000683	0.000859	CcSEcCtD
Nelarabine—Blood creatinine increased—Doxorubicin—testicular cancer	0.000681	0.000857	CcSEcCtD
Nelarabine—Neutropenia—Methotrexate—testicular cancer	0.000679	0.000854	CcSEcCtD
Nelarabine—Dehydration—Doxorubicin—testicular cancer	0.000676	0.00085	CcSEcCtD
Nelarabine—Paraesthesia—Cisplatin—testicular cancer	0.000676	0.000849	CcSEcCtD
Nelarabine—Thrombocytopenia—Etoposide—testicular cancer	0.000675	0.000848	CcSEcCtD
Nelarabine—Dyspnoea—Cisplatin—testicular cancer	0.000671	0.000843	CcSEcCtD
Nelarabine—Hypokalaemia—Doxorubicin—testicular cancer	0.000662	0.000832	CcSEcCtD
Nelarabine—Anorexia—Etoposide—testicular cancer	0.000657	0.000826	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000655	0.000823	CcSEcCtD
Nelarabine—Decreased appetite—Cisplatin—testicular cancer	0.000654	0.000822	CcSEcCtD
Nelarabine—Diarrhoea—Dactinomycin—testicular cancer	0.000652	0.000819	CcSEcCtD
Nelarabine—Pneumonia—Methotrexate—testicular cancer	0.000651	0.000819	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00065	0.000817	CcSEcCtD
Nelarabine—Vomiting—Bleomycin—testicular cancer	0.000649	0.000816	CcSEcCtD
Nelarabine—Infestation NOS—Methotrexate—testicular cancer	0.000647	0.000814	CcSEcCtD
Nelarabine—Infestation—Methotrexate—testicular cancer	0.000647	0.000814	CcSEcCtD
Nelarabine—Depression—Methotrexate—testicular cancer	0.000646	0.000812	CcSEcCtD
Nelarabine—Hypotension—Etoposide—testicular cancer	0.000644	0.00081	CcSEcCtD
Nelarabine—Pain—Cisplatin—testicular cancer	0.000643	0.000809	CcSEcCtD
Nelarabine—Muscular weakness—Doxorubicin—testicular cancer	0.000642	0.000807	CcSEcCtD
Nelarabine—Neutropenia—Epirubicin—testicular cancer	0.000635	0.000799	CcSEcCtD
Nelarabine—Abdominal distension—Doxorubicin—testicular cancer	0.000633	0.000796	CcSEcCtD
Nelarabine—Stomatitis—Methotrexate—testicular cancer	0.000631	0.000793	CcSEcCtD
Nelarabine—Asthenia—Ifosfamide—testicular cancer	0.000626	0.000787	CcSEcCtD
Nelarabine—Feeling abnormal—Cisplatin—testicular cancer	0.00062	0.000779	CcSEcCtD
Nelarabine—Paraesthesia—Etoposide—testicular cancer	0.000619	0.000778	CcSEcCtD
Nelarabine—Dyspnoea—Etoposide—testicular cancer	0.000615	0.000773	CcSEcCtD
Nelarabine—Hyperglycaemia—Epirubicin—testicular cancer	0.000613	0.000771	CcSEcCtD
Nelarabine—Somnolence—Etoposide—testicular cancer	0.000613	0.00077	CcSEcCtD
Nelarabine—Hepatobiliary disease—Methotrexate—testicular cancer	0.000612	0.00077	CcSEcCtD
Nelarabine—Epistaxis—Methotrexate—testicular cancer	0.000611	0.000768	CcSEcCtD
Nelarabine—Pneumonia—Epirubicin—testicular cancer	0.000609	0.000766	CcSEcCtD
Nelarabine—Nausea—Bleomycin—testicular cancer	0.000607	0.000763	CcSEcCtD
Nelarabine—Infestation NOS—Epirubicin—testicular cancer	0.000606	0.000762	CcSEcCtD
Nelarabine—Infestation—Epirubicin—testicular cancer	0.000606	0.000762	CcSEcCtD
Nelarabine—Vomiting—Dactinomycin—testicular cancer	0.000606	0.000761	CcSEcCtD
Nelarabine—Decreased appetite—Etoposide—testicular cancer	0.000599	0.000753	CcSEcCtD
Nelarabine—Diarrhoea—Ifosfamide—testicular cancer	0.000597	0.000751	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000595	0.000748	CcSEcCtD
Nelarabine—Body temperature increased—Cisplatin—testicular cancer	0.000595	0.000748	CcSEcCtD
Nelarabine—Fatigue—Etoposide—testicular cancer	0.000594	0.000747	CcSEcCtD
Nelarabine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000594	0.000747	CcSEcCtD
Nelarabine—Stomatitis—Epirubicin—testicular cancer	0.000591	0.000742	CcSEcCtD
Nelarabine—Constipation—Etoposide—testicular cancer	0.000589	0.000741	CcSEcCtD
Nelarabine—Pain—Etoposide—testicular cancer	0.000589	0.000741	CcSEcCtD
Nelarabine—Neutropenia—Doxorubicin—testicular cancer	0.000588	0.000739	CcSEcCtD
Nelarabine—Dizziness—Ifosfamide—testicular cancer	0.000577	0.000726	CcSEcCtD
Nelarabine—Urinary tract disorder—Methotrexate—testicular cancer	0.000574	0.000722	CcSEcCtD
Nelarabine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000573	0.00072	CcSEcCtD
Nelarabine—Epistaxis—Epirubicin—testicular cancer	0.000571	0.000718	CcSEcCtD
Nelarabine—Urethral disorder—Methotrexate—testicular cancer	0.00057	0.000716	CcSEcCtD
Nelarabine—Sinusitis—Epirubicin—testicular cancer	0.000568	0.000715	CcSEcCtD
Nelarabine—Feeling abnormal—Etoposide—testicular cancer	0.000568	0.000714	CcSEcCtD
Nelarabine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000567	0.000713	CcSEcCtD
Nelarabine—Nausea—Dactinomycin—testicular cancer	0.000566	0.000711	CcSEcCtD
Nelarabine—Pneumonia—Doxorubicin—testicular cancer	0.000564	0.000709	CcSEcCtD
Nelarabine—Gastrointestinal pain—Etoposide—testicular cancer	0.000564	0.000709	CcSEcCtD
Nelarabine—Infestation NOS—Doxorubicin—testicular cancer	0.000561	0.000705	CcSEcCtD
Nelarabine—Infestation—Doxorubicin—testicular cancer	0.000561	0.000705	CcSEcCtD
Nelarabine—Vomiting—Ifosfamide—testicular cancer	0.000555	0.000698	CcSEcCtD
Nelarabine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000549	0.000691	CcSEcCtD
Nelarabine—Stomatitis—Doxorubicin—testicular cancer	0.000546	0.000687	CcSEcCtD
Nelarabine—Body temperature increased—Etoposide—testicular cancer	0.000545	0.000685	CcSEcCtD
Nelarabine—Abdominal pain—Etoposide—testicular cancer	0.000545	0.000685	CcSEcCtD
Nelarabine—Eye disorder—Methotrexate—testicular cancer	0.000543	0.000683	CcSEcCtD
Nelarabine—Hypoaesthesia—Epirubicin—testicular cancer	0.000541	0.00068	CcSEcCtD
Nelarabine—Asthenia—Cisplatin—testicular cancer	0.00054	0.000679	CcSEcCtD
Nelarabine—Cardiac disorder—Methotrexate—testicular cancer	0.000539	0.000678	CcSEcCtD
Nelarabine—Urinary tract disorder—Epirubicin—testicular cancer	0.000537	0.000675	CcSEcCtD
Nelarabine—Oedema peripheral—Epirubicin—testicular cancer	0.000536	0.000674	CcSEcCtD
Nelarabine—Connective tissue disorder—Epirubicin—testicular cancer	0.000534	0.000672	CcSEcCtD
Nelarabine—Urethral disorder—Epirubicin—testicular cancer	0.000533	0.00067	CcSEcCtD
Nelarabine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00053	0.000666	CcSEcCtD
Nelarabine—Epistaxis—Doxorubicin—testicular cancer	0.000529	0.000665	CcSEcCtD
Nelarabine—Angiopathy—Methotrexate—testicular cancer	0.000527	0.000663	CcSEcCtD
Nelarabine—Sinusitis—Doxorubicin—testicular cancer	0.000526	0.000661	CcSEcCtD
Nelarabine—Mediastinal disorder—Methotrexate—testicular cancer	0.000524	0.000658	CcSEcCtD
Nelarabine—Chills—Methotrexate—testicular cancer	0.000521	0.000656	CcSEcCtD
Nelarabine—Nausea—Ifosfamide—testicular cancer	0.000518	0.000652	CcSEcCtD
Nelarabine—Diarrhoea—Cisplatin—testicular cancer	0.000515	0.000647	CcSEcCtD
Nelarabine—Mental disorder—Methotrexate—testicular cancer	0.000509	0.00064	CcSEcCtD
Nelarabine—Eye disorder—Epirubicin—testicular cancer	0.000508	0.000639	CcSEcCtD
Nelarabine—Malnutrition—Methotrexate—testicular cancer	0.000506	0.000636	CcSEcCtD
Nelarabine—Cardiac disorder—Epirubicin—testicular cancer	0.000505	0.000635	CcSEcCtD
Nelarabine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000501	0.000629	CcSEcCtD
Nelarabine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000497	0.000625	CcSEcCtD
Nelarabine—Oedema peripheral—Doxorubicin—testicular cancer	0.000496	0.000623	CcSEcCtD
Nelarabine—Dysgeusia—Methotrexate—testicular cancer	0.000495	0.000623	CcSEcCtD
Nelarabine—Asthenia—Etoposide—testicular cancer	0.000495	0.000622	CcSEcCtD
Nelarabine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000495	0.000622	CcSEcCtD
Nelarabine—Angiopathy—Epirubicin—testicular cancer	0.000493	0.00062	CcSEcCtD
Nelarabine—Urethral disorder—Doxorubicin—testicular cancer	0.000493	0.00062	CcSEcCtD
Nelarabine—Mediastinal disorder—Epirubicin—testicular cancer	0.00049	0.000616	CcSEcCtD
Nelarabine—Back pain—Methotrexate—testicular cancer	0.000489	0.000615	CcSEcCtD
Nelarabine—Chills—Epirubicin—testicular cancer	0.000488	0.000613	CcSEcCtD
Nelarabine—Vomiting—Cisplatin—testicular cancer	0.000478	0.000601	CcSEcCtD
Nelarabine—Vision blurred—Methotrexate—testicular cancer	0.000477	0.000599	CcSEcCtD
Nelarabine—Mental disorder—Epirubicin—testicular cancer	0.000476	0.000599	CcSEcCtD
Nelarabine—Malnutrition—Epirubicin—testicular cancer	0.000473	0.000595	CcSEcCtD
Nelarabine—Diarrhoea—Etoposide—testicular cancer	0.000472	0.000593	CcSEcCtD
Nelarabine—Eye disorder—Doxorubicin—testicular cancer	0.00047	0.000591	CcSEcCtD
Nelarabine—Anaemia—Methotrexate—testicular cancer	0.000468	0.000588	CcSEcCtD
Nelarabine—Cardiac disorder—Doxorubicin—testicular cancer	0.000467	0.000587	CcSEcCtD
Nelarabine—Dysgeusia—Epirubicin—testicular cancer	0.000464	0.000583	CcSEcCtD
Nelarabine—Back pain—Epirubicin—testicular cancer	0.000458	0.000576	CcSEcCtD
Nelarabine—Angiopathy—Doxorubicin—testicular cancer	0.000457	0.000574	CcSEcCtD
Nelarabine—Dizziness—Etoposide—testicular cancer	0.000456	0.000573	CcSEcCtD
Nelarabine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000454	0.00057	CcSEcCtD
Nelarabine—Leukopenia—Methotrexate—testicular cancer	0.000453	0.000569	CcSEcCtD
Nelarabine—Chills—Doxorubicin—testicular cancer	0.000452	0.000568	CcSEcCtD
Nelarabine—Nausea—Cisplatin—testicular cancer	0.000447	0.000562	CcSEcCtD
Nelarabine—Vision blurred—Epirubicin—testicular cancer	0.000446	0.000561	CcSEcCtD
Nelarabine—Cough—Methotrexate—testicular cancer	0.000441	0.000555	CcSEcCtD
Nelarabine—Mental disorder—Doxorubicin—testicular cancer	0.000441	0.000554	CcSEcCtD
Nelarabine—Convulsion—Methotrexate—testicular cancer	0.000438	0.000551	CcSEcCtD
Nelarabine—Vomiting—Etoposide—testicular cancer	0.000438	0.000551	CcSEcCtD
Nelarabine—Malnutrition—Doxorubicin—testicular cancer	0.000438	0.000551	CcSEcCtD
Nelarabine—Anaemia—Epirubicin—testicular cancer	0.000438	0.00055	CcSEcCtD
Nelarabine—Headache—Etoposide—testicular cancer	0.000432	0.000543	CcSEcCtD
Nelarabine—Arthralgia—Methotrexate—testicular cancer	0.000431	0.000541	CcSEcCtD
Nelarabine—Chest pain—Methotrexate—testicular cancer	0.000431	0.000541	CcSEcCtD
Nelarabine—Myalgia—Methotrexate—testicular cancer	0.000431	0.000541	CcSEcCtD
Nelarabine—Dysgeusia—Doxorubicin—testicular cancer	0.000429	0.000539	CcSEcCtD
Nelarabine—Leukopenia—Epirubicin—testicular cancer	0.000424	0.000533	CcSEcCtD
Nelarabine—Back pain—Doxorubicin—testicular cancer	0.000424	0.000533	CcSEcCtD
Nelarabine—Confusional state—Methotrexate—testicular cancer	0.000416	0.000523	CcSEcCtD
Nelarabine—Loss of consciousness—Epirubicin—testicular cancer	0.000416	0.000523	CcSEcCtD
Nelarabine—Cough—Epirubicin—testicular cancer	0.000413	0.000519	CcSEcCtD
Nelarabine—Vision blurred—Doxorubicin—testicular cancer	0.000413	0.000519	CcSEcCtD
Nelarabine—Convulsion—Epirubicin—testicular cancer	0.00041	0.000516	CcSEcCtD
Nelarabine—Infection—Methotrexate—testicular cancer	0.00041	0.000516	CcSEcCtD
Nelarabine—Nausea—Etoposide—testicular cancer	0.000409	0.000515	CcSEcCtD
Nelarabine—Nervous system disorder—Methotrexate—testicular cancer	0.000405	0.000509	CcSEcCtD
Nelarabine—Anaemia—Doxorubicin—testicular cancer	0.000405	0.000509	CcSEcCtD
Nelarabine—Thrombocytopenia—Methotrexate—testicular cancer	0.000404	0.000508	CcSEcCtD
Nelarabine—Chest pain—Epirubicin—testicular cancer	0.000403	0.000507	CcSEcCtD
Nelarabine—Arthralgia—Epirubicin—testicular cancer	0.000403	0.000507	CcSEcCtD
Nelarabine—Myalgia—Epirubicin—testicular cancer	0.000403	0.000507	CcSEcCtD
Nelarabine—Anorexia—Methotrexate—testicular cancer	0.000394	0.000495	CcSEcCtD
Nelarabine—Leukopenia—Doxorubicin—testicular cancer	0.000392	0.000493	CcSEcCtD
Nelarabine—Confusional state—Epirubicin—testicular cancer	0.00039	0.00049	CcSEcCtD
Nelarabine—Oedema—Epirubicin—testicular cancer	0.000386	0.000486	CcSEcCtD
Nelarabine—Hypotension—Methotrexate—testicular cancer	0.000386	0.000485	CcSEcCtD
Nelarabine—Loss of consciousness—Doxorubicin—testicular cancer	0.000385	0.000484	CcSEcCtD
Nelarabine—Infection—Epirubicin—testicular cancer	0.000384	0.000483	CcSEcCtD
Nelarabine—Cough—Doxorubicin—testicular cancer	0.000382	0.000481	CcSEcCtD
Nelarabine—Convulsion—Doxorubicin—testicular cancer	0.00038	0.000477	CcSEcCtD
Nelarabine—Nervous system disorder—Epirubicin—testicular cancer	0.000379	0.000476	CcSEcCtD
Nelarabine—Thrombocytopenia—Epirubicin—testicular cancer	0.000378	0.000476	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000376	0.000473	CcSEcCtD
Nelarabine—Insomnia—Methotrexate—testicular cancer	0.000373	0.000469	CcSEcCtD
Nelarabine—Arthralgia—Doxorubicin—testicular cancer	0.000373	0.000469	CcSEcCtD
Nelarabine—Chest pain—Doxorubicin—testicular cancer	0.000373	0.000469	CcSEcCtD
Nelarabine—Myalgia—Doxorubicin—testicular cancer	0.000373	0.000469	CcSEcCtD
Nelarabine—Paraesthesia—Methotrexate—testicular cancer	0.000371	0.000466	CcSEcCtD
Nelarabine—Anorexia—Epirubicin—testicular cancer	0.000368	0.000463	CcSEcCtD
Nelarabine—Dyspnoea—Methotrexate—testicular cancer	0.000368	0.000463	CcSEcCtD
Nelarabine—Somnolence—Methotrexate—testicular cancer	0.000367	0.000461	CcSEcCtD
Nelarabine—Hypotension—Epirubicin—testicular cancer	0.000361	0.000454	CcSEcCtD
Nelarabine—Confusional state—Doxorubicin—testicular cancer	0.00036	0.000453	CcSEcCtD
Nelarabine—Decreased appetite—Methotrexate—testicular cancer	0.000359	0.000451	CcSEcCtD
Nelarabine—Oedema—Doxorubicin—testicular cancer	0.000358	0.000449	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000356	0.000448	CcSEcCtD
Nelarabine—Fatigue—Methotrexate—testicular cancer	0.000356	0.000448	CcSEcCtD
Nelarabine—Infection—Doxorubicin—testicular cancer	0.000355	0.000447	CcSEcCtD
Nelarabine—Pain—Methotrexate—testicular cancer	0.000353	0.000444	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000352	0.000443	CcSEcCtD
Nelarabine—Nervous system disorder—Doxorubicin—testicular cancer	0.000351	0.000441	CcSEcCtD
Nelarabine—Thrombocytopenia—Doxorubicin—testicular cancer	0.00035	0.00044	CcSEcCtD
Nelarabine—Insomnia—Epirubicin—testicular cancer	0.000349	0.000439	CcSEcCtD
Nelarabine—Paraesthesia—Epirubicin—testicular cancer	0.000347	0.000436	CcSEcCtD
Nelarabine—Dyspnoea—Epirubicin—testicular cancer	0.000344	0.000433	CcSEcCtD
Nelarabine—Somnolence—Epirubicin—testicular cancer	0.000343	0.000432	CcSEcCtD
Nelarabine—Anorexia—Doxorubicin—testicular cancer	0.000341	0.000428	CcSEcCtD
Nelarabine—Feeling abnormal—Methotrexate—testicular cancer	0.00034	0.000428	CcSEcCtD
Nelarabine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000338	0.000424	CcSEcCtD
Nelarabine—Decreased appetite—Epirubicin—testicular cancer	0.000336	0.000422	CcSEcCtD
Nelarabine—Hypotension—Doxorubicin—testicular cancer	0.000334	0.00042	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000334	0.000419	CcSEcCtD
Nelarabine—Fatigue—Epirubicin—testicular cancer	0.000333	0.000419	CcSEcCtD
Nelarabine—Pain—Epirubicin—testicular cancer	0.00033	0.000415	CcSEcCtD
Nelarabine—Constipation—Epirubicin—testicular cancer	0.00033	0.000415	CcSEcCtD
Nelarabine—Abdominal pain—Methotrexate—testicular cancer	0.000326	0.00041	CcSEcCtD
Nelarabine—Body temperature increased—Methotrexate—testicular cancer	0.000326	0.00041	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000326	0.000409	CcSEcCtD
Nelarabine—Insomnia—Doxorubicin—testicular cancer	0.000323	0.000407	CcSEcCtD
Nelarabine—Paraesthesia—Doxorubicin—testicular cancer	0.000321	0.000404	CcSEcCtD
Nelarabine—Dyspnoea—Doxorubicin—testicular cancer	0.000319	0.000401	CcSEcCtD
Nelarabine—Feeling abnormal—Epirubicin—testicular cancer	0.000318	0.0004	CcSEcCtD
Nelarabine—Somnolence—Doxorubicin—testicular cancer	0.000318	0.0004	CcSEcCtD
Nelarabine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000316	0.000397	CcSEcCtD
Nelarabine—Decreased appetite—Doxorubicin—testicular cancer	0.000311	0.000391	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000309	0.000388	CcSEcCtD
Nelarabine—Fatigue—Doxorubicin—testicular cancer	0.000308	0.000388	CcSEcCtD
Nelarabine—Pain—Doxorubicin—testicular cancer	0.000306	0.000384	CcSEcCtD
Nelarabine—Constipation—Doxorubicin—testicular cancer	0.000306	0.000384	CcSEcCtD
Nelarabine—Body temperature increased—Epirubicin—testicular cancer	0.000305	0.000384	CcSEcCtD
Nelarabine—Abdominal pain—Epirubicin—testicular cancer	0.000305	0.000384	CcSEcCtD
Nelarabine—Asthenia—Methotrexate—testicular cancer	0.000296	0.000372	CcSEcCtD
Nelarabine—Feeling abnormal—Doxorubicin—testicular cancer	0.000295	0.00037	CcSEcCtD
Nelarabine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000292	0.000368	CcSEcCtD
Nelarabine—Abdominal pain—Doxorubicin—testicular cancer	0.000283	0.000355	CcSEcCtD
Nelarabine—Body temperature increased—Doxorubicin—testicular cancer	0.000283	0.000355	CcSEcCtD
Nelarabine—Diarrhoea—Methotrexate—testicular cancer	0.000282	0.000355	CcSEcCtD
Nelarabine—Asthenia—Epirubicin—testicular cancer	0.000277	0.000349	CcSEcCtD
Nelarabine—Dizziness—Methotrexate—testicular cancer	0.000273	0.000343	CcSEcCtD
Nelarabine—Diarrhoea—Epirubicin—testicular cancer	0.000264	0.000332	CcSEcCtD
Nelarabine—Vomiting—Methotrexate—testicular cancer	0.000263	0.00033	CcSEcCtD
Nelarabine—Headache—Methotrexate—testicular cancer	0.000259	0.000325	CcSEcCtD
Nelarabine—Asthenia—Doxorubicin—testicular cancer	0.000257	0.000322	CcSEcCtD
Nelarabine—Dizziness—Epirubicin—testicular cancer	0.000256	0.000321	CcSEcCtD
Nelarabine—Vomiting—Epirubicin—testicular cancer	0.000246	0.000309	CcSEcCtD
Nelarabine—Nausea—Methotrexate—testicular cancer	0.000245	0.000308	CcSEcCtD
Nelarabine—Diarrhoea—Doxorubicin—testicular cancer	0.000245	0.000308	CcSEcCtD
Nelarabine—Headache—Epirubicin—testicular cancer	0.000242	0.000304	CcSEcCtD
Nelarabine—Dizziness—Doxorubicin—testicular cancer	0.000236	0.000297	CcSEcCtD
Nelarabine—Nausea—Epirubicin—testicular cancer	0.00023	0.000289	CcSEcCtD
Nelarabine—Vomiting—Doxorubicin—testicular cancer	0.000227	0.000286	CcSEcCtD
Nelarabine—Headache—Doxorubicin—testicular cancer	0.000224	0.000282	CcSEcCtD
Nelarabine—Nausea—Doxorubicin—testicular cancer	0.000212	0.000267	CcSEcCtD
